PFE) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.2% year on year to $17.56 billion ... Pfizer (PFE) Q4 CY2025 Highlights. ... PFE) is a global biopharmaceutical company that ...
Global pharmaceutical company Pfizer (NYSE. PFE) will be reporting earnings this Tuesday before market open. Here’s what investors should know ... Is Pfizer a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... .
What Happened?. Shares of global pharmaceutical company Pfizer (NYSE. PFE) fell 2.5% in the morning session after the company cut its stake in its pandemic partner BioNTech by more than half, a move that overshadowed other company developments ... .